M.D. Anderson Cancer Center: Endometrial Neoplasms trials

The registry lists 37 Endometrial Neoplasms studies with M.D. Anderson Cancer Center as lead sponsor. 7 are open to participants now and 11 have results posted.

Early Phase 1 1Phase 1 6Phase 2 13Phase 3 1No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Development Of An Endometrial Cancer Educational ToolNot yet recruitingNCT07739745Not applicable
• Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial CancerRecruitingNCT07382583
• Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk WomenRecruitingNCT06409052
• Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial CancerRecruitingNCT05819892Phase 1
• Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or ThoraxRecruitingNCT05092373Phase 1
• IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsRecruitingNCT05039801Phase 1
• Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic CancersRecruitingNCT03968406Phase 1
• Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN AlterationsTerminatedNCT05082025Phase 2Results posted
• A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial CarcinomaTerminatedNCT05036681Phase 2Results posted
• Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial CancerCompletedNCT02684227Phase 2Results posted
• A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial CarcinomaCompletedNCT01797523Phase 2Results posted
• An Endometrial Cancer Chemoprevention Study of MetforminCompletedNCT01697566Phase 3Results posted
• Letrozole and RAD001 With Advanced or Recurrent Endometrial CancerActive, not recruitingNCT01068249Phase 2Results posted
• Hysteroscopic Lymphatic Mapping for Endometrial CancerTerminatedNCT00671606Phase 2Results posted
• Papillary Serous Carcinoma of the EndometriumCompletedNCT00515073Phase 2Results posted
• Cetuximab in Patients With Progressive or Recurrent Endometrial CancerCompletedNCT00392769Phase 2Results posted
• Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial CancerCompletedNCT00388154Phase 2Results posted
• RAD001 in Recurrent Endometrial Cancer PatientsCompletedNCT00087685Phase 2Results posted
• Phase 2 Study Evaluating the Efficacy of the Combination of DKN-01 (DKK1 Inhibitor, Leap Therapeutics) and Pembrolizumab in the Treatment of Advanced or Recurrent Endometrial CancerActive, not recruitingNCT05761951Phase 2
• Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) InterventionActive, not recruitingNCT05677048Not applicable
• Infertility Survey Among Reproductive Age Women With Gynecological and Breast CancerActive, not recruitingNCT04678414
• Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer SurvivorsActive, not recruitingNCT04634617
• Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their RelativesCompletedNCT04257045
• Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT03586661Phase 1
• Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal CarcinomatosisCompletedNCT03508570Phase 1
• A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial CarcinomaActive, not recruitingNCT03008408Phase 2
• Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290CompletedNCT02093546
• The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)Status unknownNCT01447199
• Evaluation of the Molecular Effects of Metformin on the Endometrium in Patients With Endometrial CancerCompletedNCT01205672Early Phase 1
• Pelvic Fractures and Radiation Therapy for Cervical CancerStatus unknownNCT00800644
• Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic CancerActive, not recruitingNCT00791635
• Combined Colon and Endometrial Cancer Screening in Women With HNPCCCompletedNCT00510796
• Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-HysterectomyCompletedNCT00508703
• Mifepristone for Patients With Endometrial Cancer and LGESSCompletedNCT00505739Phase 2
• Physical Activity After Endometrial CancerActive, not recruitingNCT00501761
• Study of Insulin Resistance and Endometrial Cancer in Harris County, TexasCompletedNCT00495235
• Chemoradiation-Induced Nausea and Emesis: Quality of LifeTerminatedNCT00394602